Growing evidence indicates that PDE4 dysregulation is of pathophysiological importance in metabolic disorders through its involvement in multiple processes, including inflammation, disordered glucose and lipid metabolism, and hepatic steatosis [12–14]. This evidence concerns the gene PDE4A and Hepatic steatosis.